Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced new analyses from its previous Phase 3 program evaluating ampreloxetine, an investigational medicine ...

At the John A. Burns School of Medicine (JABSOM), there is a new addition to the great lawn. It’s an art space unlike any other.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul ...

The Flagstaff City Council declined to move forward with a potential new design after a lengthy discussion on Tuesday, March ...

B+H’s Michele Cohen discusses the impact of virtual replicas on planning, adaptive reuse of health facilities, and future ...

As conventional approaches fail, Free Global Cities: The Future Leaders in Migration and Public Governance proposes a bold alternative — autonomous cities designed to foster economic opportunity, ...

Like Adolescence, a new report into primary school rape culture makes for painful viewing, but we can’t look away ...

Dr. Zhang Caifang, an Academician and a scientist, was appointed as the Chief Scientist of the Global Hé Project and ...

HOLLAND — Dr. Deborah Palmer sat at the cherry wood dining room table in the home of her 71-year-old patient, trying to understand why he kept waking up in the middle of the night with a ...

While the service remains nurse-led and no doctors will be on-site, the addition of prescribing nurses and access to telehealth doctors is being framed as an improvement over the previous model.

For the last six years, Dr. Rasha Alawieh studied and worked on kidney transplant cases in the United States, including in Rhode Island, under the legal protection of a H-1B work visa. That was ...

Dr. Rasha Alawieh, a physician at Brown Medicine in Rhode Island, held a "valid" H-1B visa and a court order issued on Friday prevented her removal yet she was forced to leave the country ...